These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6392471)

  • 1. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M
    J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for shigella toxin.
    Donohue-Rolfe A; Kelley MA; Bennish M; Keusch GT
    J Clin Microbiol; 1986 Jul; 24(1):65-8. PubMed ID: 3522627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.
    Eiklid K; Olsnes S
    J Immunol; 1983 Jan; 130(1):380-4. PubMed ID: 6336624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella toxin and the pathogenesis of shigellosis.
    Keusch GT; Donohue-Rolfe A; Jacewicz M
    Ciba Found Symp; 1985; 112():193-214. PubMed ID: 3847336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
    Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
    Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin.
    Islam MS; Stimson WH
    J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit structure of Shigella cytotoxin.
    Olsnes S; Reisbig R; Eiklid K
    J Biol Chem; 1981 Aug; 256(16):8732-8. PubMed ID: 7021550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity.
    Harari I; Donohue-Rolfe A; Keusch G; Arnon R
    Infect Immun; 1988 Jun; 56(6):1618-24. PubMed ID: 3286503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine.
    Mobassaleh M; Donohue-Rolfe A; Jacewicz M; Grand RJ; Keusch GT
    J Infect Dis; 1988 May; 157(5):1023-31. PubMed ID: 3283253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.